Tradestie Institutional Equity Comparison Engine
XBI vs IBB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IBB Overall Edge
IBB Captures Institutional Edge (1โ1 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to iShares Biotechnology ETF (IBB) driven by superior Momentum & Technical while XBI counters with relative strength in Options & Structure. Fundamentally, XBI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus IBB at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, XBI sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro) against IBB sits in UNCLASSIFIED (22nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
XBI N/M vs IBB N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
IBB
1Y +22.4% vs +20.8% ยท 52W Pos 47% vs 64%
Options & Structure Winner
XBI
CONSOLIDATION (17th %ile IV) vs UNCLASSIFIED (22nd %ile IV)
XBI
NYSE Arca
SPDR S&P Biotech ETF
Institutional Equity
$140.18
-2.73% 1D
Market Cap
N/A
1M Return
-7.56%
1Y Return
+22.43%
Forward P/E
N/M
Unified AI Score
52.9 / 100
HOLD
Tech 23.0
Fund 51.0
Flow 57.0
Mom 60.0
IBB
NASDAQ
iShares Biotechnology ETF
Institutional Equity
$199.54
-2.05% 1D
Market Cap
N/A
1M Return
-4.77%
1Y Return
+20.77%
Forward P/E
N/M
Unified AI Score
46.9 / 100
HOLD
Tech 27.0
Fund 47.0
Flow 50.0
Mom 56.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XBI +22.43%
IBB +20.77%
Spread: +1.66 pp (XBI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XBI TTM Op. Margin: N/A
IBB TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XBI vs IBB. Trailing 12-month operating profitability (XBI N/A vs IBB N/A) and valuation multiples (XBI N/M vs IBB N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XBI | IBB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 47% ($113โ$170) | 64% ($160โ$222) | Stronger Trend | IBB |
| Beta / 30D Volatility Risk Regime | 1.17ฮฒ ยท 38% Vol | 0.84ฮฒ ยท 29% Vol | Lower Realized Risk | IBB |
| Unified Institutional Score Composite Signal | 52.9 / 100 (HOLD) | 46.9 / 100 (HOLD) | Higher Composite | XBI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XBI vs IBB Buy Guide
XBI
CONSOLIDATION
66d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
17th %ile
IV Regime
Compressed (<25th %ile)
IBB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
22nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XBI nor IBB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.